Crinetics Pharmaceuticals
CRNX
$51.40
Share price
-0.98%
Change (1 day)
132.47%
Change (1 year)
Categories
Crinetics Pharmaceuticals (CRNX) - P/B ratio
P/B ratio as of May 2024 : 7.59
According to Crinetics Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 7.59.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Crinetics Pharmaceuticals - P/B ratio (from 2018 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.41 | 41.62% |
| 2022-12-31 | 3.11 | -23.58% |
| 2021-12-31 | 4.07 | 47.78% |
| 2020-12-31 | 2.76 | -46.96% |
| 2019-12-31 | 5.20 | 15.4% |
| 2018-12-31 | 4.50 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | -64.26% | 🇺🇸 USA |